Annual EBIT
-$9.97 M
-$28.19 M-154.77%
December 1, 2023
Summary
- As of February 8, 2025, IRD annual earnings before interest & taxes is -$9.97 million, with the most recent change of -$28.19 million (-154.77%) on December 1, 2023.
- During the last 3 years, IRD annual EBIT has risen by +$7.80 million (+43.88%).
- IRD annual EBIT is now -154.77% below its all-time high of $18.21 million, reached on December 1, 2022.
Performance
IRD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$7.53 M
+$802.00 K+9.63%
September 1, 2024
Summary
- As of February 8, 2025, IRD quarterly earnings before interest & taxes is -$7.53 million, with the most recent change of +$802.00 thousand (+9.63%) on September 1, 2024.
- Over the past year, IRD quarterly EBIT has increased by +$182.00 thousand (+2.36%).
- IRD quarterly EBIT is now -121.97% below its all-time high of $34.26 million, reached on December 1, 2022.
Performance
IRD Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$29.69 M
-$14.43 M-94.57%
September 1, 2024
Summary
- As of February 8, 2025, IRD TTM earnings before interest & taxes is -$29.69 million, with the most recent change of -$14.43 million (-94.57%) on September 1, 2024.
- Over the past year, IRD TTM EBIT has dropped by -$17.37 million (-140.99%).
- IRD TTM EBIT is now -200.16% below its all-time high of $29.64 million, reached on September 1, 2023.
Performance
IRD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
IRD EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -154.8% | +2.4% | -141.0% |
| 3 y3 years | +43.9% | -19.3% | +47.6% |
| 5 y5 years | -109.5% | -19.3% | +47.6% |
IRD EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -154.8% | +82.4% | -122.0% | +9.6% | -200.2% | +47.6% |
| 5 y | 5-year | -154.8% | +82.4% | -122.0% | +80.7% | -200.2% | +53.4% |
| alltime | all time | -154.8% | +82.4% | -122.0% | +80.7% | -200.2% | +53.4% |
Opus Genetics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.53 M(-9.6%) | -$29.69 M(+94.6%) |
| Jun 2024 | - | -$8.33 M(+8.0%) | -$15.26 M(+23.9%) |
| Mar 2024 | - | -$7.71 M(+25.8%) | -$12.32 M(+14.7%) |
| Dec 2023 | -$9.97 M(-154.8%) | -$6.13 M(-188.7%) | -$10.74 M(-136.2%) |
| Sep 2023 | - | $6.90 M(-228.1%) | $29.64 M(+62.8%) |
| Jun 2023 | - | -$5.39 M(-12.1%) | $18.20 M(-2.5%) |
| Mar 2023 | - | -$6.13 M(-117.9%) | $18.67 M(+2.5%) |
| Dec 2022 | $18.21 M | $34.26 M(-856.0%) | $18.21 M(-181.5%) |
| Sep 2022 | - | -$4.53 M(-8.0%) | -$22.36 M(+1.4%) |
| Jun 2022 | - | -$4.92 M(-25.3%) | -$22.05 M(-9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$6.59 M(+4.4%) | -$24.27 M(-57.2%) |
| Dec 2021 | -$56.69 M(+219.0%) | -$6.31 M(+49.2%) | -$56.69 M(-10.9%) |
| Sep 2021 | - | -$4.23 M(-40.7%) | -$63.63 M(+5.2%) |
| Jun 2021 | - | -$7.14 M(-81.7%) | -$60.47 M(+11.5%) |
| Mar 2021 | - | -$39.01 M(+194.3%) | -$54.25 M(+205.3%) |
| Dec 2020 | -$17.77 M(+273.4%) | -$13.26 M(+1139.9%) | -$17.77 M(+293.4%) |
| Sep 2020 | - | -$1.07 M(+16.8%) | -$4.52 M(+31.0%) |
| Jun 2020 | - | -$915.00 K(-63.9%) | -$3.45 M(+36.1%) |
| Mar 2020 | - | -$2.53 M | -$2.53 M |
| Dec 2019 | -$4.76 M | - | - |
FAQ
- What is Opus Genetics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Opus Genetics?
- What is Opus Genetics annual EBIT year-on-year change?
- What is Opus Genetics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Opus Genetics?
- What is Opus Genetics quarterly EBIT year-on-year change?
- What is Opus Genetics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Opus Genetics?
- What is Opus Genetics TTM EBIT year-on-year change?
What is Opus Genetics annual earnings before interest & taxes?
The current annual EBIT of IRD is -$9.97 M
What is the all time high annual EBIT for Opus Genetics?
Opus Genetics all-time high annual earnings before interest & taxes is $18.21 M
What is Opus Genetics annual EBIT year-on-year change?
Over the past year, IRD annual earnings before interest & taxes has changed by -$28.19 M (-154.77%)
What is Opus Genetics quarterly earnings before interest & taxes?
The current quarterly EBIT of IRD is -$7.53 M
What is the all time high quarterly EBIT for Opus Genetics?
Opus Genetics all-time high quarterly earnings before interest & taxes is $34.26 M
What is Opus Genetics quarterly EBIT year-on-year change?
Over the past year, IRD quarterly earnings before interest & taxes has changed by +$182.00 K (+2.36%)
What is Opus Genetics TTM earnings before interest & taxes?
The current TTM EBIT of IRD is -$29.69 M
What is the all time high TTM EBIT for Opus Genetics?
Opus Genetics all-time high TTM earnings before interest & taxes is $29.64 M
What is Opus Genetics TTM EBIT year-on-year change?
Over the past year, IRD TTM earnings before interest & taxes has changed by -$17.37 M (-140.99%)